Ortho Clinical Diagnostic Q1 Adj. EPS $0.23 Beats $0.20 Estimate, Sales $495.00M Miss $508.21M Estimate

Author: Benzinga Newsdesk | May 04, 2022 04:07pm
Ortho Clinical Diagnostic (NASDAQ:OCDX) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.20 by 15 percent. This is a 11.54 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $495.00 million which missed the analyst consensus estimate of $508.21 million by 2.60 percent. This is a 2.33 percent decrease over sales of $506.80 million the same period last year.

Posted In: OCDX